Xcout Intel
Endurance Biotech, Inc.
Endurance Biotech, Inc. is a biopharmaceutical company that develops first-in-class oral small molecules designed to restore mitochondrial and lysosomal function for the treatment of neurodegenerative, metabolic, and age-related diseases. Its lead clinical program, T-168, targets Parkinson's disease by addressing interconnected cellular systems, reducing neuroinflammation, and enhancing autophagy.
Subscribe to see Endurance Biotech, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Endurance Biotech, Inc. at a glance
Endurance Biotech, Inc. is a biotechnology company headquartered in United States. It has raised at least $20.5M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $11.7M in January 2018. Xcout tracks 7 named people at Endurance Biotech, Inc., including Subhasis Roy (CFO - CBO).
Endurance Biotech, Inc. leadership
- Subhasis RoyCFO - CBO
- Frederic GodderisFounder · CEO · Director
- Sanjay KakkarFounder · Director · CEO, Tensive SRL · Former Chairman, Tranquis Therapeutics
- Andrew LamCo-founder · Chief Technology Officer
- Enchi LiuCo-founder · Chief Development Officer
- Jackson StreeterFlorida Opportunity Fund / Director, UF Innovate Ventures / Partner, DeepWork Capital
1 more named person on record for Endurance Biotech, Inc., with roles, board committees and tenure — see the full roster →
Endurance Biotech, Inc. funding rounds
At least $20.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $11.7M | 1 named | |
| SEC Form D filing | $8.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Endurance Biotech, Inc. competitors
A few of Endurance Biotech, Inc.'s closest competitors — see the full list of competitors and alternatives →
Autonomy Bio Inc. is a biotechnology company focused on developing human aging therapeutics aimed at extending healthspan and mitigating age-related decline. The company targets individuals seeking to maintain health and independence as they age.
Endeavor BioMedicines, Inc. is a San Diego-based biotechnology company focused on developing novel treatments for conditions such as fibrosis.
Vandria is a biotechnology research company founded in September 2021 and based at the Biopôle campus in Epalinges, Switzerland. The company specializes in discovering first-in-class small molecules targeting mitochondrial function to treat age-related diseases. It operates with a small team focused on novel metabolic pathways.
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to treat neurodegenerative diseases by targeting specific receptor systems in the brain. The company's scientific approach focuses on restoring neurovascular and neuronal function to serve patients suffering from conditions such as Parkinson's disease and other neurodegenerative disorders.
Arkuda Therapeutics is a biotechnology company developing small-molecule treatments for neurodegenerative diseases, with a focus on restoring lysosomal function and addressing progranulin-related disease biology. Its programs are aimed particularly at patients with frontotemporal dementia and other disorders involving lysosomal dysfunction.
Synendos Therapeutics is a clinical-stage biopharmaceutical and neuroscience company focused on developing a novel class of small molecules to treat psychiatric and neurological disorders.
Get Endurance Biotech, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Endurance Biotech, Inc. in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access